[Tyr0] Gastric Inhibitory Peptide (23-42), human

Modify Date: 2024-01-17 15:12:05

[Tyr0] Gastric Inhibitory Peptide (23-42), human Structure
[Tyr0] Gastric Inhibitory Peptide (23-42), human structure
Common Name [Tyr0] Gastric Inhibitory Peptide (23-42), human
CAS Number 121765-67-1 Molecular Weight 2584.93
Density N/A Boiling Point N/A
Molecular Formula C119H182N34O31 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of [Tyr0] Gastric Inhibitory Peptide (23-42), human


[Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research[1][2].

 Names

Name [Tyr0] Gastric Inhibitory Peptide (23-42), human

  Biological Activity

Description [Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion. [Tyr0] Gastric Inhibitory Peptide (23-42), human can be used in diabetes, obesity research[1][2].
Related Catalog
In Vivo GIPR-/- mice have higher blood glucose levels and impaired initial insulin response after oral glucose loading. In GIPR+/+ mice, a high-fat diet did not increase postprandial intake blood glucose levels, whereas it significantly increased in GIPR-/- mice[2].

 Chemical & Physical Properties

Molecular Formula C119H182N34O31
Molecular Weight 2584.93
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here